Dimerix Ltd (ASX:DXB, OTC:SBMJF) has moved to strengthen the clinical and regulatory footing of its lead kidney disease ...
Lyell Immunopharma (LYEL) has made significant progress with respect to its CD19/CD20 CAR-T cell therapy targeting patients with aggressive 3rd-line + Large B-Cell Lymphoma [LBCL]. The reason why is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results